Article
Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] - 1 Dec 2003
Sullivan Tory P, Dearaujo Tami, Vincek Vladimir, Berman Brian
Abstract excerpt
OBJECTIVE: To characterize the immune response and the apoptotic pathways that result in regression of imiquimod-treated basal cell carcinomas (BCCs). METHODS: The trial was conducted as an open-label, matched controlled, nonrandomized study. Twelve patients were assigned as either active-treatment patients or matched control subjects. After treatment, lesions were excised and stained for CD20, CD3, CD4, CD56,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.